Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Functional Magnetic Resonance Imaging in the Diagnosis of Locally Recurrent Prostate Cancer: Are All Pulse Sequences Helpful?

  • Liao, Xiao-Li (Department of First Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University) ;
  • Wei, Jun-Bao (Department of Therapeutic Radiology, Affiliated Tumor Hospital of Guangxi Medical University) ;
  • Li, Yong-Qiang (Department of First Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University) ;
  • Zhong, Jian-Hong (Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University) ;
  • Liao, Cheng-Cheng (Department of Third Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University) ;
  • Wei, Chang-Yuan (Department of Breast Surgery, Affiliated Tumor Hospital of Guangxi Medical University)
  • Received : 2017.08.03
  • Accepted : 2018.04.24
  • Published : 2018.12.01
⟨ Previous Next ⟩

Abstract

Objective: To perform a meta-analysis to quantitatively assess functional magnetic resonance imaging (MRI) in the diagnosis of locally recurrent prostate cancer. Materials and Methods: A comprehensive search of the PubMed, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews was conducted from January 1, 1995 to December 31, 2016. Diagnostic accuracy was quantitatively pooled for all studies by using hierarchical logistic regression modeling, including bivariate modeling and hierarchical summary receiver operating characteristic (HSROC) curves (AUCs). The Z test was used to determine whether adding functional MRI to T2-weighted imaging (T2WI) results in significantly increased diagnostic sensitivity and specificity. Results: Meta-analysis of 13 studies involving 826 patients who underwent radical prostatectomy showed a pooled sensitivity and specificity of 91%, and the AUC was 0.96. Meta-analysis of 7 studies involving 329 patients who underwent radiotherapy showed a pooled sensitivity of 80% and specificity of 81%, and the AUC was 0.88. Meta-analysis of 11 studies reporting 1669 sextant biopsies from patients who underwent radiotherapy showed a pooled sensitivity of 54% and specificity of 91%, and the AUC was 0.85. Sensitivity after radiotherapy was significantly higher when diffusion-weighted MRI data were combined with T2WI than when only T2WI results were used. This was true when meta-analysis was performed on a per-patient basis (p = 0.027) or per sextant biopsy (p = 0.046). A similar result was found when $^1H$-magnetic resonance spectroscopy ($^1H$-MRS) data were combined with T2WI and sextant biopsy was the unit of analysis (p = 0.036). Conclusion: Functional MRI data may not strengthen the ability of T2WI to detect locally recurrent prostate cancer in patients who have undergone radical prostatectomy. By contrast, diffusion-weight MRI and $^1H$-MRS data may improve the sensitivity of T2WI for patients who have undergone radiotherapy.

Keywords

Acknowledgement

Supported by : Guangxi Medical University, Guangxi Natural Science Foundation

References

  1. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010;19:1893-1907 https://doi.org/10.1158/1055-9965.EPI-10-0437
  2. Freedland SJ, Presti JC Jr, Amling CL, Kane CJ, Aronson WJ, Dorey F, et al. Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology 2003;61:736-741 https://doi.org/10.1016/S0090-4295(02)02526-8
  3. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517-523 https://doi.org/10.1016/S0022-5347(05)63946-8
  4. Rinnab L, Mottaghy FM, Blumstein NM, Reske SN, Hautmann RE, Hohl K, et al. Evaluation of [11C]-choline positronemission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int 2007;100:786-793 https://doi.org/10.1111/j.1464-410X.2007.07083.x
  5. Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:380-385 https://doi.org/10.1016/j.ijrobp.2003.10.059
  6. Lee WR, Hanks GE, Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol 1997;15:230-238 https://doi.org/10.1200/JCO.1997.15.1.230
  7. Bianco FJ Jr, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:448-453 https://doi.org/10.1016/j.ijrobp.2004.09.049
  8. Roach M 3rd. The role of PSA in the radiotherapy of prostate cancer. Oncology (Williston Park) 1996;10:1143-1153; discussion 1154-1161
  9. Luzurier A, Jouve De Guibert PH, Allera A, Feldman SF, Conort P, Simon JM, et al. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: limited added value for readers of varying level of experience. J Magn Reson Imaging 2018 Mar 8 [Epub ahead of print]. https://doi.org/10.1002/jmri.25991
  10. Mazaheri Y, Shukla-Dave A, Goldman DA, Moskowitz CS, Takeda T, Reuter VE, et al. Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla. Magn Reson Imaging 2018 Aug 31 [Epub ahead of print]. pii: S0730-725X(18)30428-4. https://doi.org/10.1016/j.mri.2018.08.025
  11. Wu LM, Xu JR, Gu HY, Hua J, Zhu J, Chen J, et al. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy. Clin Oncol (R Coll Radiol) 2013;25:252-264 https://doi.org/10.1016/j.clon.2012.11.010
  12. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration Web site. https://training.cochrane.org/ handbook. Published March 20, 2011. Accessed January 30, 2016
  13. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Int J Surg 2010;8:336-341 https://doi.org/10.1016/j.ijsu.2010.02.007
  14. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al.; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-536 https://doi.org/10.7326/0003-4819-155-8-201110180-00009
  15. Hollingworth W, Medina LS, Lenkinski RE, Shibata DK, Bernal B, Zurakowski D, et al. Interrater reliability in assessing quality of diagnostic accuracy studies using the QUADAS tool. A preliminary assessment. Acad Radiol 2006;13:803-810 https://doi.org/10.1016/j.acra.2006.03.008
  16. Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 2006;59:1331-1332; author reply 1332-1333 https://doi.org/10.1016/j.jclinepi.2006.06.011
  17. Wang F, Gatsonis CA. Hierarchical models for ROC curve summary measures: design and analysis of multi-reader, multimodality studies of medical tests. Stat Med 2008;27:243-256 https://doi.org/10.1002/sim.2828
  18. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998;316:61-66 https://doi.org/10.1136/bmj.316.7124.61
  19. Harbord RM, Egger M, Sterne JA. A modified test for smallstudy effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006;25:3443-3457 https://doi.org/10.1002/sim.2380
  20. Kim CK, Park BK, Lee HM. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 2009;29:391-397 https://doi.org/10.1002/jmri.21645
  21. Tamada T, Sone T, Jo Y, Hiratsuka J, Higaki A, Higashi H, et al. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors. AJR Am J Roentgenol 2011;197:408-414 https://doi.org/10.2214/AJR.10.5772
  22. Carbone SF, Pirtoli L, Ricci V, Carfagno T, Tini P, La Penna A, et al. Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases. Biomed Res Int 2014;2014:780816
  23. Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS, et al. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrastenhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 2013;268:440-450 https://doi.org/10.1148/radiol.13122149
  24. Kitajima K, Hartman RP, Froemming AT, Hagen CE, Takahashi N, Kawashima A. Detection of local recurrence of prostate cancer after radical prostatectomy using endorectal coil MRI at 3 T: addition of DWI and dynamic contrast enhancement to T2-weighted MRI. AJR Am J Roentgenol 2015;205:807-816 https://doi.org/10.2214/AJR.14.14275
  25. Hara T, Inoue Y, Satoh T, Ishiyama H, Sakamoto S, Woodhams R, et al. Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy. Magn Reson Imaging 2012;30:1091-1098 https://doi.org/10.1016/j.mri.2012.04.022
  26. Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Menard C, et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:425-430 https://doi.org/10.1016/j.ijrobp.2007.06.029
  27. Rouviere O, Valette O, Grivolat S, Colin-Pangaud C, Bouvier R, Chapelon JY, et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings. Urology 2004;63:922-927 https://doi.org/10.1016/j.urology.2003.12.017
  28. Silverman JM, Krebs TL. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 1997;168:379-385 https://doi.org/10.2214/ajr.168.2.9016212
  29. Westphalen AC, Kurhanewicz J, Cunha RM, Hsu IC, Kornak J, Zhao S, et al. T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. Int Braz J Urol 2009;35:171-180; discussion 181-182 https://doi.org/10.1590/S1677-55382009000200007
  30. Morgan VA, Riches SF, Giles S, Dearnaley D, deSouza NM. Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol 2012;198:596-602 https://doi.org/10.2214/AJR.11.7162
  31. Pucar D, Shukla-Dave A, Hricak H, Moskowitz CS, Kuroiwa K, Olgac S, et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 2005;236:545-553 https://doi.org/10.1148/radiol.2362040739
  32. Sella T, Schwartz LH, Swindle PW, Onyebuchi CN, Scardino PT, Scher HI, et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004;231:379-385 https://doi.org/10.1148/radiol.2312030011
  33. Sciarra A, Panebianco V, Salciccia S, Osimani M, Lisi D, Ciccariello M, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008;54:589-600 https://doi.org/10.1016/j.eururo.2007.12.034
  34. Panebianco V, Sciarra A, Lisi D, Galati F, Buonocore V, Catalano C, et al. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 2012;81:700-708 https://doi.org/10.1016/j.ejrad.2011.01.095
  35. Cirillo S, Petracchini M, Scotti L, Gallo T, Macera A, Bona MC, et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 2009;19:761-769 https://doi.org/10.1007/s00330-008-1174-8
  36. Casciani E, Polettini E, Carmenini E, Floriani I, Masselli G, Bertini L, et al. Endorectal and dynamic contrast enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 2008;190:1187-1192 https://doi.org/10.2214/AJR.07.3032
  37. Linder BJ, Kawashima A, Woodrum DA, Tollefson MK, Karnes J, Davis BJ, et al. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol 2014;21:7283-7289
  38. Wassberg C, Akin O, Vargas HA, Shukla-Dave A, Zhang J, Hricak H. The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience. AJR Am J Roentgenol 2012;199:360-366 https://doi.org/10.2214/AJR.11.6923
  39. Boonsirikamchai P, Kaur H, Kuban DA, Jackson E, Hou P, Choi H. Use of maximum slope images generated from dynamic contrast-enhanced MRI to detect locally recurrent prostate carcinoma after prostatectomy: a practical approach. AJR Am J Roentgenol 2012;198:W228-W236 https://doi.org/10.2214/AJR.10.6387
  40. Westphalen AC, Coakley FV, Roach M 3rd, McCulloch CE, Kurhanewicz J. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology 2010;256:485-492 https://doi.org/10.1148/radiol.10092314
  41. Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M 3rd, et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 2004;233:441-448 https://doi.org/10.1148/radiol.2332032086
  42. Abd-Alazeez M, Ramachandran N, Dikaios N, Ahmed HU, Emberton M, Kirkham A, et al. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrastenhanced images. Prostate Cancer Prostatic Dis 2015;18:128-136 https://doi.org/10.1038/pcan.2014.55
  43. Kim CK, Park BK, Park W, Kim SS. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging 2010;35:246-252 https://doi.org/10.1007/s00261-008-9495-2
  44. Panebianco V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V, et al. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol 2013;23:1745-1752 https://doi.org/10.1007/s00330-013-2768-3
  45. Kara T, Akata D, Akyol F, Karc˛aaltincaba M, Ozmen M. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings. Diagn Interv Radiol 2011;17:38-43
  46. Drudi FM, Giovagnorio F, Carbone A, Ricci P, Petta S, Cantisani V, et al. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy--comparison with MRI. Ultraschall Med 2006;27:146-151
  47. Coakley FV, Hricak H, Wefer AE, Speight JL, Kurhanewicz J, Roach M. Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes. Radiology 2001;219:817-821 https://doi.org/10.1148/radiology.219.3.r01jn46817
  48. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate. Prostate 1991;19:181-205 https://doi.org/10.1002/pros.2990190302
  49. Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005;234:804-814 https://doi.org/10.1148/radiol.2343040363
  50. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002;16:451-463 https://doi.org/10.1002/jmri.10172
  51. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243:28-53 https://doi.org/10.1148/radiol.2431030580